Study Finds 6% Rate of New Persistent Opioid Use After Ureteroscopy
A study found that 6.2% of opioid-naïve patients became persistent users of opioids following ureteroscopy for upper tract stones.
Kidney Stones
KIDNEY STONES
Kidney Stones Linked to High Animal Protein Intake
Compared with the lowest quintiles of total animal protein intake and non-dairy animal protein intake, the highest quintiles were associated with a 16% and 14% increased risks of kidney stone formation, respectively, a study found. Findings are consistent with previous studies.
Wide Regional Variation Found in Lithotripsy Use for Medicare Patients
Study reveals up to a 12-fold difference between hospital referral regions in the use of shock wave lithotripsy to the treatment of Medicare beneficiaries with kidney stones.
Ureteral Access Sheath During Ureteroscopic Stone Removal Safe
In a single institution series, no intraoperative complications occurred when a ureteral access sheath (UAS) was using during flexible ureteroscopy for stone removal and the stone-free rate was similar to that achieved when a UAS was not used.
Post-Ureteroscopy UTI Risk Factors Identified
Female sex, prior urinary tract infection, and longer operative time are associated with increased odds of UTI following flexible ureteroscopy, a study found.
SWL, Ureteroscopy Offer Similar Efficacy in Pediatric Stone Cases
Shock wave lithotripsy (SWL) and ureteroscopy are associated with similar stone clearance rates in children, but morbidity is less with SWL, according to a new study.
Stone Formation in an HIV Patient Two Years After Stopping Ritonavir
A recently published report describes the case of a 33-year-old female patient with HIV who experienced ritonavir-induced nephrolithiasis 2 years after discontinuing the medication.
CT Use to Evaluate Suspected Urolithiasis Significantly Increased
2006 to 2014 saw more than doubling in the use of CTAP in the ED, with considerable geographic variation
Thiola EC Approved for Treatment of Cystinuria
A new enteric-coated formulation of Thiola has been approved by the Food and Drug Administration for the prevention of cystine stone formation.
Study: Stone Characteristics Should Guide Early Intervention
Patients with high-risk stones wider than 7.0 mm or wider than 5 mm located in the proximal-middle ureter should be offered early surgery, according to researchers.
Want to read more?
Please login or register first to view this content.